Cargando…

Edaravone Dexborneol Downregulates Neutrophil Extracellular Trap Expression and Ameliorates Blood-Brain Barrier Permeability in Acute Ischemic Stroke

BACKGROUND: Our previous work has shown that inflammatory processes play a detrimental role in the pathophysiology of acute ischemic stroke (AIS). Neutrophil extracellular traps (NETs) have been recognized as a key contributor to the proinflammatory response in AIS and could aggravate blood-brain ba...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Yuanxiang, Zhang, Xiangjian, Zhang, Cong, Xu, Wenting, Li, Wenshuo, Feng, Zixin, Zhang, Xianglan, Zhao, Keke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9410976/
https://www.ncbi.nlm.nih.gov/pubmed/36032782
http://dx.doi.org/10.1155/2022/3855698
_version_ 1784775218052464640
author Huang, Yuanxiang
Zhang, Xiangjian
Zhang, Cong
Xu, Wenting
Li, Wenshuo
Feng, Zixin
Zhang, Xianglan
Zhao, Keke
author_facet Huang, Yuanxiang
Zhang, Xiangjian
Zhang, Cong
Xu, Wenting
Li, Wenshuo
Feng, Zixin
Zhang, Xianglan
Zhao, Keke
author_sort Huang, Yuanxiang
collection PubMed
description BACKGROUND: Our previous work has shown that inflammatory processes play a detrimental role in the pathophysiology of acute ischemic stroke (AIS). Neutrophil extracellular traps (NETs) have been recognized as a key contributor to the proinflammatory response in AIS and could aggravate blood-brain barrier (BBB) damage. Recently, experimental and clinical researches showed that Edaravone Dexborneol (Eda.B), which is comprised of two active ingredients, Edaravone and (+)-Borneol, was effective in treatment of AIS. However, it is not clear whether the effects of Eda.B against AIS are related to NETs and BBB permeability. METHODS: Experiment 1 was to detect the effects of Eda.B in AIS patients. Serum samples of volunteers and AIS patients were collected before and 3 days after Edaravone Dexborneol treatment. Markers of NETs and occludin were detected by ELISA kit. Experiment 2 was to explore the effects of Eda.B on experimental stroke mice. Male C57BL/6 mice were subjected to distal middle cerebral artery occlusion (MCAO) and treated with vehicle, Eda.B, or DeoxyribonueleaseI (DNase I). After stroke, the neurobehavioral tests, infarct volume, and cerebral blood flow evaluation were determined. Leakage of Evans blue was to assess the integrity of BBB. Western blot, real-time quantitative polymerase chain reaction (RT-qPCR), and immunofluorescence were used to examine the expression of NETs and tight junction- (TJ-) associated proteins. RESULTS: Eda.B significantly improved neurological function and cerebral blood flow but reduced infarct volume after experimental stroke. Eda.B downregulated level of NETs in serum samples of AIS patients and tissue samples of MCAO mouse cortex. Eda.B and DNase I alleviated BBB permeability by upregulating TJ-associated proteins. CONCLUSION: NETs are related to the early stage of AIS. Eda.B exerted neuroprotective effects and ameliorated BBB permeability after AIS.
format Online
Article
Text
id pubmed-9410976
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-94109762022-08-26 Edaravone Dexborneol Downregulates Neutrophil Extracellular Trap Expression and Ameliorates Blood-Brain Barrier Permeability in Acute Ischemic Stroke Huang, Yuanxiang Zhang, Xiangjian Zhang, Cong Xu, Wenting Li, Wenshuo Feng, Zixin Zhang, Xianglan Zhao, Keke Mediators Inflamm Research Article BACKGROUND: Our previous work has shown that inflammatory processes play a detrimental role in the pathophysiology of acute ischemic stroke (AIS). Neutrophil extracellular traps (NETs) have been recognized as a key contributor to the proinflammatory response in AIS and could aggravate blood-brain barrier (BBB) damage. Recently, experimental and clinical researches showed that Edaravone Dexborneol (Eda.B), which is comprised of two active ingredients, Edaravone and (+)-Borneol, was effective in treatment of AIS. However, it is not clear whether the effects of Eda.B against AIS are related to NETs and BBB permeability. METHODS: Experiment 1 was to detect the effects of Eda.B in AIS patients. Serum samples of volunteers and AIS patients were collected before and 3 days after Edaravone Dexborneol treatment. Markers of NETs and occludin were detected by ELISA kit. Experiment 2 was to explore the effects of Eda.B on experimental stroke mice. Male C57BL/6 mice were subjected to distal middle cerebral artery occlusion (MCAO) and treated with vehicle, Eda.B, or DeoxyribonueleaseI (DNase I). After stroke, the neurobehavioral tests, infarct volume, and cerebral blood flow evaluation were determined. Leakage of Evans blue was to assess the integrity of BBB. Western blot, real-time quantitative polymerase chain reaction (RT-qPCR), and immunofluorescence were used to examine the expression of NETs and tight junction- (TJ-) associated proteins. RESULTS: Eda.B significantly improved neurological function and cerebral blood flow but reduced infarct volume after experimental stroke. Eda.B downregulated level of NETs in serum samples of AIS patients and tissue samples of MCAO mouse cortex. Eda.B and DNase I alleviated BBB permeability by upregulating TJ-associated proteins. CONCLUSION: NETs are related to the early stage of AIS. Eda.B exerted neuroprotective effects and ameliorated BBB permeability after AIS. Hindawi 2022-08-18 /pmc/articles/PMC9410976/ /pubmed/36032782 http://dx.doi.org/10.1155/2022/3855698 Text en Copyright © 2022 Yuanxiang Huang et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Huang, Yuanxiang
Zhang, Xiangjian
Zhang, Cong
Xu, Wenting
Li, Wenshuo
Feng, Zixin
Zhang, Xianglan
Zhao, Keke
Edaravone Dexborneol Downregulates Neutrophil Extracellular Trap Expression and Ameliorates Blood-Brain Barrier Permeability in Acute Ischemic Stroke
title Edaravone Dexborneol Downregulates Neutrophil Extracellular Trap Expression and Ameliorates Blood-Brain Barrier Permeability in Acute Ischemic Stroke
title_full Edaravone Dexborneol Downregulates Neutrophil Extracellular Trap Expression and Ameliorates Blood-Brain Barrier Permeability in Acute Ischemic Stroke
title_fullStr Edaravone Dexborneol Downregulates Neutrophil Extracellular Trap Expression and Ameliorates Blood-Brain Barrier Permeability in Acute Ischemic Stroke
title_full_unstemmed Edaravone Dexborneol Downregulates Neutrophil Extracellular Trap Expression and Ameliorates Blood-Brain Barrier Permeability in Acute Ischemic Stroke
title_short Edaravone Dexborneol Downregulates Neutrophil Extracellular Trap Expression and Ameliorates Blood-Brain Barrier Permeability in Acute Ischemic Stroke
title_sort edaravone dexborneol downregulates neutrophil extracellular trap expression and ameliorates blood-brain barrier permeability in acute ischemic stroke
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9410976/
https://www.ncbi.nlm.nih.gov/pubmed/36032782
http://dx.doi.org/10.1155/2022/3855698
work_keys_str_mv AT huangyuanxiang edaravonedexborneoldownregulatesneutrophilextracellulartrapexpressionandamelioratesbloodbrainbarrierpermeabilityinacuteischemicstroke
AT zhangxiangjian edaravonedexborneoldownregulatesneutrophilextracellulartrapexpressionandamelioratesbloodbrainbarrierpermeabilityinacuteischemicstroke
AT zhangcong edaravonedexborneoldownregulatesneutrophilextracellulartrapexpressionandamelioratesbloodbrainbarrierpermeabilityinacuteischemicstroke
AT xuwenting edaravonedexborneoldownregulatesneutrophilextracellulartrapexpressionandamelioratesbloodbrainbarrierpermeabilityinacuteischemicstroke
AT liwenshuo edaravonedexborneoldownregulatesneutrophilextracellulartrapexpressionandamelioratesbloodbrainbarrierpermeabilityinacuteischemicstroke
AT fengzixin edaravonedexborneoldownregulatesneutrophilextracellulartrapexpressionandamelioratesbloodbrainbarrierpermeabilityinacuteischemicstroke
AT zhangxianglan edaravonedexborneoldownregulatesneutrophilextracellulartrapexpressionandamelioratesbloodbrainbarrierpermeabilityinacuteischemicstroke
AT zhaokeke edaravonedexborneoldownregulatesneutrophilextracellulartrapexpressionandamelioratesbloodbrainbarrierpermeabilityinacuteischemicstroke